EICHORCondition: Hodgkin Lymphoma · Sponsor: University College, London
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
RADAR is a multicentre, international, randomised, open-label phase III clinical trial composed of 2 trials running in parallel. Trial 1 will be led and sponsored by University College London (UCL) and conducted in Europe and Australia/New Zealand. Trial 2 will be led by the Canadian Cancer Trials Group (CCTG) and conducted in North America, with CCTG the regulatory sponsor in Canada, and University of Miami the regulatory sponsor and IND holder in the US. Datasets from Trial 1 and Trial 2 will be combined to achieve the total sample size. Data analysis will be performed by UCL and therefore UCL is responsible for the clinicaltrials.gov entry. Eligible patients will be randomised to receive either ABVD or A2VD chemotherapy. An interim PET-CT scan will be performed after 2 cycles of treatment, which will be used to adapt subsequent treatment. Patients will receive a total of 3-4 cycles of chemotherapy and may also receive involved site radiotherapy as consolidation. Patients will be followed up for a minimum of 5 years after treatment.
This description comes directly from the study's public registry record.
RADAR Trial Coordinator · +44(0)207 679 9860 · ctc.radar@ucl.ac.uk
Always discuss trial participation with your own doctor first.
| Stanford University - (Stanford Cancer Institute) | Stanford, California, United States | Recruiting |
| University of Miami School of Medicine | Miami, Florida, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Royal North Shore Hospital | Saint Leonards, New South Wales, Australia | Recruiting |
| Townsville University Hospital | Townsville, Queensland, Australia | Recruiting |
| Royal Adelaide Hospital | Adelaide, Australia | Recruiting |
| Box Hill Hospital | Box Hill, Australia | Recruiting |
| Royal Brisbane and Women's Hospital | Brisbane, Australia | Recruiting |
| Royal Darwin Hospital | Darwin, Australia | Recruiting |
| Liverpool Hospital | Liverpool, Australia | Recruiting |
| Sunshine Hospital (Western Health) | Melbourne, Australia | Recruiting |
| Concord Repatriation General Hospital | Sydney, Australia | Recruiting |
+ 60 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04685616